Market Tracker

09/29 7:40am ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

3.29
Delayed Data
As of Sep 28
 +0.05 / +1.54%
Today’s Change
3.16
Today|||52-Week Range
34.40
-80.87%
Year-to-Date
No recent news for Orexigen Therapeutics Inc.

Today’s Trading

Previous close3.24
Today’s open3.21
Day’s range3.16 - 3.33
Volume207,713
Average volume (3 months)204,786
Market cap$47.3M
Dividend yield--
Data as of 09/28/2016

Growth & Valuation

Earnings growth (last year)-62.50%
Earnings growth (this year)-33.65%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-55.95%
P/E ratioNM
Price/Sales9.22
Price/Book1.41

Competitors

 Today’s
change
Today’s
% change
NVETNexvet Biopharma plc-0.08-1.98%
CNATConatus Pharmaceutic...-0.01-0.48%
IMMYImprimis Pharmaceuti...-0.02-0.53%
PTXPernix Therapeutics ...-0.00-0.75%
Data as of 09/28/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$2.22
Annual revenue (last year)$24.5M
Annual profit (last year)-$68.7M
Net profit margin-280.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts